- Message from the Director
- Chair, Board of Governors Message
- Board of Governors
- Leadership
- Sylvester Locations
- Sylvester by the Numbers
-
- Sylvester Investigator’s Hodgkin Lymphoma Protocol Could Change Care for Relapsed, Refractory Patients
- Sylvester Physician-Scientist Receives Doris Duke Charitable Foundation Grant
- Junior Researcher Lands Competitive Grants for Pancreatic Cancer Focus
- Sylvester Researcher Chosen for Bristol Myers Squibb Foundation’s Career Development Program
- Sylvester Part of Groundbreaking NIH Trial Proving Anal Cancer Can Be Prevented
- The Childhood Cancer Project Focuses On Cures
-
- Health Economist Heads Commission to Examine Global Cancer Care Inequities
- Dr. Chad Ritch Appointed Member of American College of Surgeons Commission on Cancer
- Sylvester Launches New Program To Prevent Breast Cancer In Those At High Risk
- VA Honors Investigator For Gastric Cancer Research
- Keeping Cancer In Its Place: Key Protein Identified
- Phase 1 Program
-
- WHO Taps Sylvester in Global Fight Against Cervical Cancer
- Groundbreaking Research
- Community Outreach
- Orthopaedic Surgeon, Researcher Dr. Francis Hornicek Returns To Miami
- Sarcoma Specialist’s Return Elevates Sylvester Orthopaedic Oncology
- Dr. Marijo Bilusic Joins Sylvester as Genitourinary Site Leader
- Cancer Control Leader Joins Sylvester
- Educational Pathways Fuel Robust Cancer Research Pipeline
- Target: Multiple Myeloma Cure
- Educator
-
- Committed to Survivors’ Quality of Life
- Multidisciplinary Clinic
- Tackling Hispanic Cancer Disparities
- Training The Next Generation of Researchers in Disparities, Equity
- Researcher Drives Efforts To Educate Youth About E-Cigs, Hookahs
- Sylvester Studies Cancer Patient Advocacy Group’s Impact on Outcomes
- Clinic Addresses Sexual Dysfunction In Cancer Survivors
-
71st
NCI-Designated Cancer Center
in the Country
1 of 2
NCI-Designated
cancer centers in Florida
33
NEW PHYSICIANS AND
PHYSICIAN-SCIENTISTS
1,500+
PHYSICIANS,
PHYSICIAN-SCIENTISTS AND
SUPPORT STAFF
DEVOTED EXCLUSIVELY TO
CANCER CARE AND RESEARCH
1,978
STEM CELL TRANSPLANTS
AND T CELL THERAPIES
COMPLETED SINCE
PROGRAM’S INCEPTION
4,102
PATIENTS PARTICIPATING
IN 300 CLINICAL STUDIES
(INTERVENTIONAL AND
NON-INTERVENTIONAL);
109 OF THE TRIALS BECAME
AVAILABLE TO PATIENTS IN 2021
9
Treatment facilites
across South Florida
15
Cancer site
disease groups
397
Cancer-relevant,
peer-reviewed publications,
213 with other NCI-Designated
cancer centers
12
CANCER SUPPORT SERVICES
AND 17 CANCER
SUPPORT GROUPS
$56.3M
IN PEER-REVIEWED AND
NON-PEER-REVIEWED FUNDING
FOR 480 ACTIVE CANCER
PROJECTS; $29.3M IN PEER-
REVIEWED FUNDING (OF WHICH
$9.8M IS FROM NCI); $3.6M FOR
TRAINING GRANTS (ADDITIONAL)
305
PATIENTS TREATED WITH
PROTON THERAPY(SINCE THE DWOSKIN PROTON
THERAPY CENTER OPENED ON
SEPTEMBER 11, 2020)
